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Background
Healthy animals perform better than those that are dis-
eased; therefore there are significant benefits from pre-
venting disease on farm by investigating new vaccine
delivery systems. Recently, viral vectors have risen to
prominence as candidates for generating immune
responses. Of these viral candidates, lentiviruses are
attractive as they have the ability to transduce non-
dividing antigen presenting cells. For example, lentiviral
vectors have been shown to produce an antigen-
mediated immune response in mice, providing long
term, sterile protection against Malaria[1].
Material and methods
Transformed human embryonic kidney (293T) cells were
transfected with four plasmids which encode the various
vector components for the production of lentiviral vectors.
Vectors produced so far contain an eGFP reporter cassette
to facilitate measurement of infectivity by flow cytometry.
Self-inactivating (SIN) vectors have been produced to
decrease the probability of the generation of replication-
competent virus[2]. To produce a SIN vector, viral enhan-
cers and promoter sequences were deleted by Gibson
Cloning leaving expression of transgenes controlled by an
internal promoter. Integrase deficient lentiviral vectors
were produced by introducing point mutations by PCR on
the D,D-35-E motif within the integrase protein to reduce
insertional oncogenesis[3].
Results
Stable expression of antigens is important to a success-
ful vaccine, therefore the stability of ovine lentiviral
transduction was evaluated over a 4 week period with
eGFP-positive cells measured periodically. 50% of cells
remained eGFP-positive after 4 weeks in rapidly dividing
cells suggesting a sustained, stable transduction. Ovine
lentivirus vectors have the ability to infect a wide range
of cell types from different species with similar efficiency
to the well characterised murine leukaemia virus (MLV)
vector. Self-inactivating vectors with non-active LTRs
retain the ability to express transgenes in vitro. Integra-
tion deficient vectors appear to have to correct pheno-
type as eGFP-positive cells decreased over time in
dividing cells.
Conclusion
We have created a novel, self-inactivating, integration
deficient ovine lentiviral vector which retains the ability
to express transgenes in vitro. Future studies will inves-
tigate ovine lentiviral vectors mechanisms of immune
response in vitro and study their efficiency to deliver
appropriate immunity in vivo.
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